Contract DOCSB134115SU1063
Medix Biochemica USA, Inc. · Department Of Commerce · September 21, 2015
Medix Biochemica USA, Inc. was awarded a federal contract by Department Of Commerce (National Institute Of Standards And Technology) on September 21, 2015 for an undisclosed amount of work in medicinal and botanical manufacturing. Performance is in Maryland Heights, MO. It was awarded under a small business set-aside. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on December 9, 2016.
Contract details
- PIID
- DOCSB134115SU1063
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- Small Business Set Aside - Total
- Competition
- Competed Under Sap
- NAICS
- 325411 · Medicinal And Botanical Manufacturing
- Product / service
- Chemicals
- Place of performance
- Maryland Heights, MO
- First action
- September 21, 2015
- Latest action
- December 9, 2016
Description
CLOSEOUT
Modification timeline
-
December 9, 2016Mod 2$0
-
September 15, 2016Mod 1MANUFACTURE OF BILIRUBIN$-15.0K
-
September 21, 2015Base awardMANUFACTURE OF BILIRUBIN$15.0K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Life Technologies Corporation | Department Of Commerce | September 10, 2024 | $83.8K |
| Merck Eprova Ag | Department Of Commerce | August 21, 2010 | $11.3K |
| Argent Chemical Laboratories Inc | Department Of Commerce | June 4, 2009 | $18.4K |
| Sigma-Aldrich Corporation | Department Of Commerce | July 28, 2008 | $-1.4K |
Top contractors in NAICS 325411
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 372,977 | $24.02B |
| 2 | Amerisourcebergen Drug Corp | 1,414,856 | $18.32B |
| 3 | Glaxosmithkline, Llc | 44 | $5.42B |
| 4 | Merck Sharp & Dohme Llc | 3 | $1.50B |
| 5 | Novartis Vaccines And Diagnostics, Inc. | 132 | $1.07B |
| 6 | Sanofi Vaccines Us Inc. | 57 | $650.53M |
| 7 | Cardinal Health, Inc. | 42,916 | $603.29M |
| 8 | Dms Pharmaceutical Group Inc | 113,930 | $547.06M |
| 9 | Cardinal Health 100, Inc | 7,655 | $486.24M |
| 10 | Glaxosmithkline Holdings (Americas) Inc. | 72 | $280.01M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract DOCSB134115SU1063?
Contract DOCSB134115SU1063 is a federal contract awarded to Medix Biochemica USA, Inc. by Department Of Commerce on September 21, 2015 for an undisclosed amount of work classified under MEDICINAL AND BOTANICAL MANUFACTURING. It has been modified 2 times since the base award.
Who won contract DOCSB134115SU1063?
Medix Biochemica USA, Inc. won contract DOCSB134115SU1063 from Department Of Commerce.
How much is contract DOCSB134115SU1063 worth?
Contract DOCSB134115SU1063 has no obligated funds in the available record. It may be a pre-award placeholder or an indefinite-delivery vehicle awaiting task orders.